Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies
Key takeaways
- (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies Neha Gupta Sun, May 17, 2026 at 11:54 PM GMT+7 2 min read TMO Thermo Fisher Scientific Inc.
- The new center in Plainville, Massachusetts, is designed to bring life-changing therapies to patients.
- The opening of the Bioprocess Design Center is a significant milestone as Thermo Fisher Scientific seeks to enhance drug development.
Thermo Fisher Scientific Inc. (TMO) Unveils Bioprocess Design Center to Develop Life-Changing Therapies Neha Gupta Sun, May 17, 2026 at 11:54 PM GMT+7 2 min read TMO Thermo Fisher Scientific Inc. (NYSE:TMO) is one of billionaire Steve Cohen’s large-cap stock picks with the highest upside potential. On April 28, Thermo Fisher Scientific Inc. (NYSE:TMO) opened a new Bioprocess Design Center.
The new center in Plainville, Massachusetts, is designed to bring life-changing therapies to patients. In addition, customers will be able to partner with the company’s experts to address complex bioprocessing challenges. The center features 4,000 square feet of laboratory and training space where customers can access comprehensive bio-production solutions and expert scientists and engineers.
The opening of the Bioprocess Design Center is a significant milestone as Thermo Fisher Scientific seeks to enhance drug development. That’s in part because the center will help customers unlock productivity gains, reduce risks as they scale, and shorten timelines. The center is also positioned to strengthen connections and collaborations across the country by creating more opportunities to share innovation.